Abbott India

44
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE358A01014
  • NSEID: ABBOTINDIA
  • BSEID: 500488
INR
25,980.00
350.2 (1.37%)
BSENSE

Oct 09

BSE+NSE Vol: 3.91 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 8.11% vs 9.58% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 11.65% vs 16.62% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 118.64% vs -8.19% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 9.73% vs 17.75% in Mar 2025

Compare Profit and Loss Results of Abbott India
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6,929.00
2,346.00
4,583.00
195.35%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6,929.00
2,346.00
4,583.00
195.35%
Expenditure (Ex Depriciation)
Stock Adjustments
-85.00
-118.00
33.00
27.97%
Raw Materials Consumed
3,778.00
1,187.00
2,591.00
218.28%
Power & Fuel Cost
14.00
215.00
-201.00
-93.49%
Employee Cost
668.00
467.00
201.00
43.04%
Operating Expenses
145.00
165.00
-20.00
-12.12%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
159.00
45.00
114.00
253.33%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
66.00
9.00
57.00
633.33%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5,036.00
2,120.00
2,916.00
137.55%
Operating Profit (PBDIT) excl Other Income
1,892.00
226.00
1,666.00
737.17%
Other Income
288.00
319.00
-31.00
-9.72%
Operating Profit (PBDIT)
2,180.00
545.00
1,635.00
300.00%
Interest
24.00
142.00
-118.00
-83.10%
Profit before Depriciation and Tax
2,155.00
403.00
1,752.00
434.74%
Depreciation
75.00
137.00
-62.00
-45.26%
Profit Before Taxation & Exceptional Items
2,079.00
266.00
1,813.00
681.58%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2,079.00
51.00
2,028.00
3,976.47%
Provision for Tax
527.00
13.00
514.00
3,953.85%
Profit After Tax
1,552.00
37.00
1,515.00
4,094.59%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3,220.00
10,468.00
-7,248.00
-69.24%
Profit Available for appropriations
4,772.00
10,505.00
-5,733.00
-54.57%
Appropriations
4,772.00
10,505.00
-5,733.00
-54.57%
Equity Dividend (%)
6560%
10%
6,550.00
Earnings Per Share
730.36
0.27
730.09
270,403.70%
Profit And Loss - Net Sales
Net Sales 6,929.05 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 8.11% vs 9.58% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,892.08 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.65% vs 16.62% in Mar 2025

Profit And Loss - Interest
Interest 24.99 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 118.64% vs -8.19% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 1,552.02 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 9.73% vs 17.75% in Mar 2025